Phase II Study to Evaluate the Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis

This study is currently recruiting participants.

Study NCT00295854 Information provided by MediciNova

First Received: February 22, 2006 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given